Cartalax – 20mg

Description

For Research Use Only. Supplied exclusively for laboratory research. Not for human or veterinary use.

Cartalax 20mg Research Peptide

Cartalax is the short peptide Ala-Glu-Asp, also described in research literature as AED or T-31. Zentra Brands supplies this product as a 20mg vial for controlled laboratory research. Each current batch is independently analysed, with the matching certificate available through the Batch Verification Centre.

Technical Specifications

Reference chemistry describes the peptide, not a completed analysis of this batch. Consult the final batch documentation for confirmed identity, composition and analytical results.

Batch Testing and Documentation

Each current batch is independently analysed, with the matching certificate available through the Batch Verification Centre. The matching certificate is available in the Batch Verification and COA Centre.

Storage and Laboratory Handling

Follow the batch-specific supplier instructions and your laboratory’s validated procedures. Protect the sealed material from moisture and contamination. Record the lot identifier when preparing experiments and consult the research peptide storage guide for general background. Consult the matching batch certificate and supplied documentation alongside the laboratory’s validated storage procedures.

Cartalax Research FAQs

What is Cartalax?

Cartalax is the AED tripeptide, consisting of alanine, glutamic acid and aspartic acid.

What size is this product?

This listing is for one 20mg vial; the value identifies nominal vial content, not a usage instruction.

Is the batch testing complete?

Yes. Each current batch is independently analysed, with the matching certificate available through the Batch Verification Centre.

Is Cartalax the same as Epithalon?

No. They have different peptide sequences and must not be treated as interchangeable research materials.

Is this for human or veterinary use?

No. It is intended exclusively for laboratory research.

Selected Research and Reference Sources

• Peptide Regulation of Gene Expression: A Systematic Review — includes Cartalax (AED) in its review of short-peptide research and discusses regulation of cartilage-related cellular functions and gene-expression models.
• Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers — identifies Cartalax (AED) and summarizes its reported experimental research context.
• Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro — additional AED cell-model research.
• AED reference chemistry — Cayman Chemical

External references describe research or reference materials; they are not certificates for the Zentra Brands batch.

Research Resources

• Batch verification and analytical reports
• Epithalon research product information
• Research peptide catalogue

For research use only. Not for human or veterinary use.